# Sodium Chloride and Contrast Nephropathy

> **NCT03476460** · PHASE2 · COMPLETED · sponsor: **Hospital Universitario Ramon y Cajal** · enrollment: 271 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Kidney Failure, Acute
- Heart Failure
- Diabetes

## Interventions

- **DRUG:** Oral sodium chloride
- **DRUG:** Intravenous sodium chloride

## Key facts

- **NCT ID:** NCT03476460
- **Lead sponsor:** Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2019-11-29
- **Final completion:** 2019-11-29
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476460, "Sodium Chloride and Contrast Nephropathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03476460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*